Lewes, DE -- (ReleaseWire) -- 08/20/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Take-Two Interactive Software, Inc. (NASDAQ:TTWO), Solta Medical Inc (NASDAQ:SLTM), VIVUS, Inc. (NASDAQ:VVUS), Array Biopharma Inc (NASDAQ:ARRY)
Take-Two Interactive Software, Inc. (NASDAQ:TTWO) opened its shares at the price of $18.45 for the day. Its closing price was $17.99 after losing -2.02% for the day. The company traded with the total volume of 1.54 million shares, while its average trading volume remained 1.85 million shares. The beta of TTWO stands at1.62.
Take-Two Interactive Software, Inc. is a developer, marketer and publisher of interactive entertainment for consumers worldwide.
Has TTWO Found The Bottom and Ready To Move Up? Find Out Here
Solta Medical Inc (NASDAQ:SLTM) percentage change surged +5.88% to close at $2.16 with the total traded volume of 1.53 million shares, and average volume of 842,553.00 shares. The 52 week range of the stock remained $1.44 - $3.35, while its day lowest price was $2.05 and it hit its day highest price at $2.22.
Solta Medical, Inc. designs, develops, manufactures and markets professional and consumer energy-based medical device systems for aesthetic applications.
Why Should Investors Buy SLTM After The Recent Gain? Just Go Here and Find Out
VIVUS, Inc. (NASDAQ:VVUS) started its trading session with the price of $12.29 and closed at $12.09 by scoring -1.55%. VVUS’s stocks traded with total volume of 1.53 million shares, while the average trading volume remained 2.67 million shares. The beta of VVUS stands at 1.32. Day range of the stock was $11.97 -$12.49.
VIVUS, Inc. is a biopharmaceutical company. It commercializes and develops therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health.
Has VVUS Found The Bottom and Ready To Move Up? Find Out Here
Array Biopharma Inc (NASDAQ:ARRY) ended its day with the loss of -0.16% and closed at the price of $6.09 after opening at $6.06. Stock traded during its last trading session with the total volume of 1.54 million shares, as compared to its average volume of 2.00 million shares.
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases.
Has ARRY Found The Bottom And Ready To Gain Momentum? Find Out Here
LeadingStockAlertsis a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/